Host-microbiome Metatranscriptomic Targets for Drug Development

Time: 5:10 pm
day: Day One – Track A – 3


• Viome has built its ViOS platform with 350,000+ samples of host+microbiome gene expression data with associated rich phenotypes
• Viome has developed a rapid target identification method (days to weeks per indication) for defining and stratifying a large range of chronic diseases
• As an example, we show the types of host and microbiome transcripts we identified for IBD, many of which can be pursued into drug development using multiple modalities